Dicerna Pharmaceuticals
DRNA
#3949
Rank
S$3.85 B
Marketcap
S$49.49
Share price
0.00%
Change (1 day)
16,672.22%
Change (1 year)

Market capitalization of Dicerna Pharmaceuticals (DRNA)

Last known market cap: S$3.85 Billion

As of December 2025 Dicerna Pharmaceuticals has a market cap of S$3.85 Billion. This makes Dicerna Pharmaceuticals the world's 3949th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Dicerna Pharmaceuticals from 2014 to 2022

End of year Market Cap

Year Marketcap Change
2022S$3.99 B-0.84%
2021S$4.02 B82.33%
2020S$2.20 B3.86%
2019S$2.12 B113.39%
2018S$0.99 B59.72%
2017S$0.62 B621.03%
2016S$86.5 M-74.98%
2015S$0.34 B-10.67%
2014S$0.38 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Regulus Therapeutics
RGLS
S$0.73 B-81.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
S$12.32 B 219.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$189.79 B 4,822.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$69.18 B 1,694.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$315.72 B 8,088.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$219.89 B 5,603.26%๐Ÿ‡บ๐Ÿ‡ธ USA